DJO 2Q19 Growth Driven by Joint Replacement Sales

• Colfax leadership is pleased with the continuing integration of DJO, noting “good engagement and associate feedback”
• Joint replacement growth driven by product innovation and relationships with key opinion leaders, including positive surgeon response to the EMPOWR knee
• Colfax’s operations improvement plan for DJO includes continuous improvement of procurement and supply chain, with a focus on the reimbursement process and product innovation
• Leadership noted that the DJO purchase gives them new directions to pursue acquisitions that can improve both the scale and reach of Colfax

Performance by Segment

ORTHOWORLD estimates segment sales and growth on an as-reported basis, as follows ($MM):

Sources: Colfax Corp.; ORTHOWORLD estimates.

Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.